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Background: The Cystic Fibrosis Transmembrane conductance Regulator (CFTR) is a chloride channel that primarily
resides in airway epithelial cells. Decreased CFTR expression and/or function lead to impaired airway surface liquid
(ASL) volume homeostasis, resulting in accumulation of mucus, reduced clearance of bacteria, and chronic infection
and inflammation.
Methods: Expression of CFTR and the cigarette smoke metal content were assessed in lung samples of controls
and COPD patients with established GOLD stage 4. CFTR protein and mRNA were quantified by
immunohistochemistry and quantitative RT-PCR, respectively. Metals present in lung samples were quantified by
ICP-AES. The effect of cigarette smoke on down-regulation of CFTR expression and function was assessed using
primary human airway epithelial cells. The role of leading metal(s) found in lung samples of GOLD 4 COPD patients
involved in the alteration of CFTR was confirmed by exposing human bronchial epithelial cells 16HBE14o- to
metal-depleted cigarette smoke extracts.
Results: We found that CFTR expression is reduced in the lungs of GOLD 4 COPD patients, especially in bronchial
epithelial cells. Assessment of metals present in lung samples revealed that cadmium and manganese were
significantly higher in GOLD 4 COPD patients when compared to control smokers (GOLD 0). Primary human airway
epithelial cells exposed to cigarette smoke resulted in decreased expression of CFTR protein and reduced airway
surface liquid height. 16HBE14o-cells exposed to cigarette smoke also exhibited reduced levels of CFTR protein and
mRNA. Removal and/or addition of metals to cigarette smoke extracts before exposure established their role in
decrease of CFTR in airway epithelial cells.
Conclusions: CFTR expression is reduced in the lungs of patients with severe COPD. This effect is associated with
the accumulation of cadmium and manganese suggesting a role for these metals in the pathogenesis of COPD.
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Chronic obstructive pulmonary disease (COPD) is the
third leading cause of death in the US since 2008 [1].
The two major clinical phenotypes in COPD in the lung
are emphysema and chronic bronchitis. Chronic bron-
chitis is a disease of the airways while emphysema char-
acterizes the airspaces that are involved in gas exchange
[2,3]. The severity of obstruction or airflow limitation in
COPD is classified based on the Global Initiative for* Correspondence: boyaka.2@osu.edu
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unless otherwise stated.Chronic Obstructive Lung Disease (GOLD) criteria with
GOLD 1 being mild COPD and GOLD 4 very severe
COPD.
CFTR is a chloride channel that primarily resides in the
apical membrane of epithelial cells. CFTR plays a major
role in maintaining ASL volume and hence maintaining
normal physiology of the lung. Mutations of the CFTR
chloride channel result in cystic fibrosis, which is an auto-
somal recessive disorder common in Caucasians and char-
acterized by thick viscid mucus secretion blocking the
airways leading to recurrent infections by resistant organ-
isms [4]. In the past few years, increasing evidence has
linked cigarette smoke exposure and dysregulation of ionLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Anthropometric characteristics and pulmonary
function data of human subjects
Variables GOLD 0 GOLD 4 p value
(n = 9) (n = 11)
Age, years 65.1 ± 7.4 55.5 ± 1.9 0.09 (n.s.)
Male/Female gender 5/3 4/6 -
Smoking, pack-year 22.5 ± 12.1 58 ± 10.8 0.02*
Stop years 32.8 ± 8.9 7.2 ± 7.7 3.4 × 10−6**
FEV1, % predicted 103.4 ± 7.3 18.1 ± 1.2 3.47 × 10−10**
FVC, % predicted 100.8 ± 8.1 48.5 ± 3.7 6 × 10−10**
FEV1/FVC 75 ± 1.9 32 ± 3.9 4 × 10−8**
Data are presented as mean ± SEM; n.s., non significant; *p < 0.05, **p < 0.01.
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mucus dehydration [5-8]. Thus, it has been hypothesized
that cigarette smoke-induced CFTR dysfunction contrib-
utes to the development of chronic bronchitis.
We and others recently reported that heavy metals such
as arsenic and cadmium down-regulate the expression of
the CFTR protein in human airway epithelial cells [9,10].
Since cigarettes contain high amounts of metals including
cadmium and arsenic (0.87 and 0.17 μg/g) [11], we investi-
gated their contribution in cigarette smoke-induced
down-regulation of CFTR. Due to the central role played
by CFTR in the lung, the present study investigated
whether the expression of CFTR was affected or not in
the lung of COPD patients with a history of smoking.
Herein we show that CFTR protein is decreased in
bronchial epithelial cells from patients with severe
COPD (GOLD 4). We also identified heavy metals
present in cigarette smoke as major down-regulators of
CFTR expression.
Materials and methods
Isolation and culture of human bronchial epithelial cells
Primary human bronchial epithelial cells (HBEC) were iso-
lated from excess donor tissue obtained at the time of lung
transplantation under a protocol approved by UNC Med-
ical School IRB. Primary HBEC were cultured as previously
described and studied when fully differentiated [8,12].
Human bronchial epithelial cells 16HBE14o- that express
endogenous CFTR, kindly provided by Dr. Gruenert, were
cultured in Minimum Essential medium (MEM) supple-
mented with 10% fetal bovine serum, 1% L-glutamine, and
1% penicillin/streptomycin in a humidified CO2 incubator
(37°C, 5% CO2). The flasks and plates were coated with an
extracellular matrix cocktail comprised of bovine serum
albumin (Invitrogen), human fibronectin (BD Laboratories),
and collagen (BD Laboratories).
Subjects and sample collection
Human lung samples were obtained from the Lung Tissue
Research Consortium (LTRC, NIH) approved project
(Concept Sheet #09-99-0017). The LTRC Patients were
classified into two groups based on lung function tests
with GOLD 4 having an FEV1/FVC < 70%, FEV1 < 30%
predicted or <50% normal with chronic respiratory
failure, and GOLD 0 being asymptomatic with normal
lung function (Table 1). Patients from both groups had
a history of smoking except one patient in control group
(GOLD 0).
Whole cigarette smoke and cigarette smoke extract (CSE)
preparation
HBECs were exposed to whole cigarette smoke (CS) with
a LM1 smoke engine (Borgwaldt) calibrated to deliver
a volume/surface area of CS that approximates in vivoexposure [8]. HBECs were serosally perfused with KBR
solution during the whole cigarette smoke exposure
period. For chronic smoke exposure (5 days) HBECs
were exposed to smoke from 2 cigarettes and replaced
in the incubator in fresh media between smoke expo-
sures. Smoke was generated according to ISO stan-
dards (1 puff = 2 second/35 ml draw). Two cigarettes
approximately equaled 30 puffs of smoke.
Cigarette smoke from one non-filtered cigarette was
bubbled using a peristaltic pump apparatus into 10 ml of
complete culture media (Minimum Essential Medium
with 10% fetal bovine serum, 1% L-glutamine, and 1%
penicillin/streptomycin), which was designated as 100%
CSE. The CSE was prepared from commercial Camel
cigarettes (RJ Reynolds). Each experiment has been per-
formed with at least three separate preparations of CSE.
Non-filtered cigarettes were chosen since filters remove
the particulate fraction which contains metals [13].Immunohistochemistry
Immunostaining of CFTR in formalin fixed, paraffin
embedded 4 μm thick sections was performed using
the Ventana Benchmark LT System and the universal
fast red and DAB (red and brown color, respectively)
detection systems. The polyclonal rabbit CFTR anti-
body (Abcam, Cambridge, MA) was used at a dilution
of 1:125 for human lung tissues. Optimal conditions
included antigen retrieval for 30 min at 95°C using the
Ventana Cell Conditioning Antigen retrieval solution #1.
This solution is the standard pH 8.5 Tris-EDTA antigen
retrieval solution. Negative control was performed by
adding rabbit non-immune IgG. Lung sections that did
not have bronchial epithelium were excluded. Each slide
(representing one patient) was given a score from 1–3
by three independent pathologists/trained researchers
(blinded to the results) based upon quantification of the
CFTR staining in terms of intensity, localization and
number of positive cells.
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The height of the ASL was measured as previously de-
scribed [14]. Briefly, PBS containing 2 mg/ml rhodamine-
dextran (10 kDa; Invitrogen, USA) was added to the
apical side of polarized human bronchial epithelial cells.
A total of five predetermined points (one central, four
2 mm from the edge of the culture) were XZ scanned
using a confocal microscope (Leica SP5; glycerol 63×
immersion lens). Between time points, the cultures were
returned to a humidified CO2 incubator and incubated
at 37°C in presence of 5% CO2. In order to prevent
evaporation of the ASL, perfluorocarbon was added api-
cally during imaging.Surface biotinylation
Apical membrane proteins were biotinylated as previ-
ously described [15]. Briefly, polarized human bronchial
epithelial cells were washed three times with PBS sup-
plemented with 1 mM MgCl2 and 1 mM CaCl2 (PBS-
CM). Sulfo-NHS-biotin (0.5 mg/ml) in borate buffer
(85 mM NaCl, 4 mM KCl, 15 mM Na2B4O7, pH 9) was
applied onto the apical membrane and incubated for
30 min with gentle agitation. PBS-CM supplemented
with 10% (v/v) FBS was added to the basolateral bath to
prevent biotinylation of basolateral proteins. Cells were
lysed in lysis buffer (0.4% sodium deoxycholate, 1% NP-
40, 50 mM EGTA, 10 mM Tris-Cl, pH 7.4 and Protease
inhibitor) and protein concentration was determined by
BCA assay. Three hundred micrograms of total protein
were incubated overnight with 100 μl of neutravidin
agarose beads at 4°C with agitation. Biotinylated pro-
teins bound to beads were washed three times with lysis
buffer and eluted in 30 μl of Laemmli buffer supple-
mented with 10% (v/v) β-mercaptoethanol by first incu-
bating at room temperature for 10 minutes, followed by
heating at 95°C for another 10 minutes.Western blotting
Cells were lysed in phosphate buffered saline (PBS) contain-
ing 0.2% Triton-X100 and a cocktail of protease inhibitors
(Roche). Proteins were detected as previously described
using the specific primary antibody diluted at 1:2,000 for
C-CFTR (R and D Systems), 1:1000 for Na+/K+-ATPase
(Santa Cruz Biotechnology) or 1:10,000 for β-actin (Santa
Cruz Biotechnology) [9,16].LDH cytotoxicity assay
Lactate dehydrogenase (LDH) released into the medium
was measured using the Tox7 kit (Sigma-Aldrich) by
following the manufacturer’s instructions. Results are
expressed as percent of total LDH content which was
obtained using 1% Triton X-100.Quantitative RT-PCR (qRT-PCR) analysis
Quantitative RT-PCR was employed to measure the tran-
script levels of the cftr gene and was performed as previ-
ously described [9,17]. RT-PCR for amplifying transcripts
of the cftr gene was performed at least three times to con-
firm the accuracy of the results. The CFTR mRNA was
normalized to the expression of the housekeeping gene
(CAP-1) and expressed as relative copy number (RCN).
RCN = 2ΔCt × 100 where ΔCt = Cycle threshold (Ct) of
CFTR - Ct of the house keeping gene (CAP-1).
Elemental analysis
The metal content of tissue samples was determined by
inductively-coupled plasma atomic emission spectrom-
etry (ICP-AES). Flash frozen tissues obtained from the
LTRC were transferred to pre-weighed polypropylene
tubes and desiccated for 12–16 hours at 60°C. The dried
pellets were weighed and dissolved in OmniTrace 70%
HNO3 (EMD Chemicals) overnight at 60°C with slow
orbital shaking. Tissue acid lysates were then diluted to
5% HNO3 with OmniTrace water (EMD Chemicals),
clarified by centrifugation (3000 × g for 10 min), and in-
troduced via a pneumatic concentric nebulizer using
argon carrier gas into a Vista Pro ICP-AES (Varian Inc)
within 1–2 hours of sample preparation as previously
described [18]. All reagents and plasticware were certi-
fied or routinely tested for trace metal work. Elemental
content data was summarized using native software
(ICP Expert; Varian, Inc) and normalized to dry weight
of tissue sample.
Statistical analysis
Data are expressed as mean ± standard error of the mean
(SEM) or median with 25% and 75% quartiles of at least
3 independent experiments. Statistically significant differ-
ences were assessed using Student’s t-test and Mann–
Whitney U test for analyzing immunohistochemistry re-
sults. p values < 0.05 were considered significant.
Results
Cigarette smoke alters ASL in primary human bronchial
epithelial cells
CFTR is a chloride channel which regulates hydration of
the airway surface liquid (ASL) layer [19]. Absence of
functional CFTR from the plasma membrane of bronchial
epithelial cells results in impaired mucociliary clearance
due to reduced airway surface liquid. Previous report
showed that acute exposure of primary bronchial epithe-
lial cells to cigarette smoke exerts a transient decrease
in ASL height [8]. In order to mimic chronic smoking,
human primary bronchial epithelial cells were grown in
air/liquid interface and subjected to cigarette smoke for
up to 120 hours. The height of the ASL was monitored
and decreased significantly upon exposure to cigarette
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the CFTR protein has to be present at the plasma mem-
brane of airway epithelial cells. Exposure to cigarette
smoke lead to significant loss of plasma membrane CFTR
(Figure 1B). Taken together, our results show that cigarette
smoke decreases the expression of CFTR resulting in re-
duced ASL.
Cigarette smoke decreases the expression of the CFTR
protein in human bronchial epithelial cells
The human airway epithelial cell line 16HBE14o- was
used as a model for bronchial epithelial cells that express
the CFTR protein [9]. Confluent 16HBE14o− cells treated
mucosally with 10% cigarette smoke extract (CSE) from
commercial grade cigarettes (Camel) for 0 to 48 hoursFigure 1 Chronic exposure to cigarette smoke (CS) decreases
airway surface liquid (ASL) height. Primary human airway
epithelial cells from 4 donors (n = 8) were exposed to 30 puffs of
whole cigarette smoke (2 cigarettes) every day for 5 days (120 hrs).
(A) ASL height was measured one hour after each exposure to CS.
ASL height was undisturbed over the course of the reading.
*p < 0.05. (B) CFTR present at the plasma membrane was detected
by immunoblotting after biotinylation of cell surface proteins
(see Methods).showed a time-dependent decrease in CFTR protein ex-
pression (Figure 2A). We focused on non-filtered ciga-
rettes since CSE prepared from filtered cigarettes have
limited down-regulation effect on CFTR protein when
cells are exposed acutely (Additional file 1: Figure S1). We
then exposed 16HBE14o- cells to increasing concentra-
tions of CSE (5-20%) and observed a dose-dependent de-
crease in CFTR protein expression in response to CSE
(Figure 2B). Conversely, CSE did not decrease the expres-
sion of the membrane protein Na+/K+-ATPase as seen in
Figure 2B (middle panel). To assess whether CSE also af-
fected CFTR mRNA, 16HBE14o- cells were treated with
CSE. CSE down-regulated CFTR mRNA transcript levels
by about 60% (Figure 2C).
It has to be noted that 16HBE14o- cells exposed to
CSE exhibited no signs of toxicity as determined by the
LDH cytotoxicity assay (7.5% ± 4.9 vs 6.0% ± 4.2 for con-
trol and 10% CSE, respectively).
CFTR is decreased in the lung of GOLD 4 COPD patients
We investigated the effect of long-term cigarette smoking
on the expression of CFTR in vivo. Although all the pa-
tients included in the study had a history of cigarette
smoking (except one never smoker patient in control
group), they all had quit smoking when the samples
were collected (except one patient in GOLD 4 group
who was a current smoker). As shown in Figure 3, ex-
pression of CFTR protein was much weaker in the bron-
chial epithelium of the COPD GOLD 4 group when
compared to the GOLD 0 group (Figure 3A). The inten-
sity of the CFTR signal was found to be significantly re-
duced in bronchial epithelial cells from patients with
GOLD 4 COPD (Figure 3C). No CFTR signal could be
detected when non-immnune IgG was used instead of
CFTR antibody (Figure 3B). Accordingly, CFTR mRNA
transcript levels were significantly lower in lung samples
from GOLD 4 COPD patients when compared to
GOLD 0 (Figure 3D).
Comprehensive assessment of metal content in the lung
We and others have reported that the pollutant metals
such as arsenic and cadmium can affect the expression
and function of CFTR [9,20,21]. We therefore performed
a comprehensive assessment of metals present in the lung
of COPD patients using ICP-AES by focusing on metals
originating from cigarette smoke [22]. This analysis re-
vealed significantly greater accumulation of cadmium and
manganese in the lung of COPD GOLD 4 patients when
compared to GOLD 0 patients (Figure 4B and E). It has to
be noted that the amounts of cadmium present in GOLD
0 patients were below the detection level. On the other
hand, no difference was seen between the amount of
aluminum, chromium, copper, and zinc detected in GOLD
0 and GOLD 4 lung samples (Figure 4A, C, D, and F).
Figure 2 Cigarette smoke extract (CSE) decreases the expression of CFTR but not Na+/K+-ATPase in human bronchial epithelial cells.
16HBE14o- cells were treated with 10% CSE for up to 48 hours (A) or increasing concentrations of CSE prepared from commercial grade
cigarettes (Camel) for 48 hours (B). CFTR and Na+/K+-ATPase were detected by immunoblotting. The same amount of protein was loaded in each
lane as indicated by detection of β-actin. The blots are representative of at least three independent experiments. (C) Detection of CFTR mRNA
transcript levels using quantitative RT-PCR analysis after treatment of 16HBE14o- cells with 10% CSE for 24 hours. Results are expressed as fold
change and are representative of three independent experiments. *p < 0.05.
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tection level in all lung tissues from both patient groups.
Role of metals present in cigarette smoke in regulation of
CFTR protein
We next investigated whether metals present in cigarette
smoke were involved in decrease of CFTR in bronchial
epithelial cells. Metals were removed from CSE using
Chelex-100 beads, which is a solid-state chelator resin that
binds many divalent metals. Removal of the metals pre-
vented the CSE-induced down-regulation of CFTR protein
observed with CSE not treated with Chelex-100 beads
(Figure 5, lanes 2 and 3). On the other hand, addition of
cadmium to CSE treated with Chelex-100 beads resulted
in a decrease in CFTR protein expression (Figure 5, lane
4). Since manganese was the other metal that was present
at higher levels in the lungs of patients with COPD when
compared to controls, we investigated whether manganese
alone had any effect on CFTR in human bronchial epithe-
lial cells. As observed in Figure 6, both cadmium and
manganese could decrease the expression of CFTR.Discussion
COPD is a complex disease with multifactorial etiology.
Numerous mechanisms have been implicated in the
pathogenesis of COPD [23-25], yet no curative treatment
has emerged, and currently there is no approach avail-
able to stop the progression of the disease. One of the
main phenotypes of COPD is chronic bronchitis which
is characterized by mucus secretion, chronic infection
and inflammation. Recent studies showed that cigarette
smoke could decrease CFTR function in nasal epithelial
cells in smokers [5,8]. CFTR is a chloride channel that
plays a major role in regulating ASL hydration and its
activation prevents mucus accumulation in the lung
[19]. However, little is known about whether CFTR ex-
pression is affected in COPD patients with a history of
smoking but some studies have suggested that it could
play a role in chronic bronchitis [26,27]. Our study
shows that cigarette smoke decreases CFTR expression
and function in human bronchial epithelial cells and that
the expression of the CFTR protein is also reduced in
bronchial epithelium of patients with severe (GOLD 4)
Figure 3 CFTR is decreased in the lung of GOLD 4 COPD patients. (A) CFTR protein was detected in the lung of GOLD 0 (Control 1 and 2)
and GOLD 4 (Patient 1 and 2) patients. Formalin fixed paraffin embedded lung tissue sections from GOLD 0 and GOLD 4 patients were
immunostained using a specific CFTR antibody (red) (A) or non-immune control (B). (C) Intensity of CFTR signal was scored as described in the
Methods section. (D) The CFTR mRNA level was measured by quantitative RT-PCR and expressed as Relative Copy Number (RCN). N = 7 for
number of patients GOLD 0 and N = 8 for number of patients COPD GOLD 4. Statistically significant differences were assessed using
Mann–Whitney U test.
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(GOLD 0).
Cigarette smoking has been firmly established as the
major cause of COPD, but approximately one-quarter of
American adults continue to smoke, despite aggressive
smoking prevention and cessation efforts [28]. On the
other hand, despite the association between smoking
and airway obstruction only 10 to 20% of smokers de-
velop COPD. Here we show that CFTR protein is signifi-
cantly decreased in the lung of COPD patients with
severe phenotype (GOLD 4) when compared to control
patients (GOLD 0). We focused on bronchial epithelial
cells since CFTR is primarily expressed in those cells in
the lung [29]. CFTR has also been reported to be expressed
in type II pneumocytes [30]. However, due to the large
destruction of the alveoli, we could not determine
whether or not absence of CFTR signal was due to loss
of CFTR protein or type II cells (data not shown).
CFTR function can be measured in vivo by measuring
nasal potential differences (NPD). Cantin et al. and Clunes
et al., have previously reported that current smokers have
reduced CFTR function when assessing NPD [5,8]. One
limitation of our study is that we were not able to measureCFTR function in vivo in COPD patients or control sub-
jects due to the fact that the human samples were ob-
tained from the Lung Tissue Research Consortium
(LTRC) at the NIH and we did not have access to the
patients. However, we show that chronic exposure to
cigarette smoke decreases the expression of CFTR at
the plasma membrane of primary human airway epithe-
lial cells that was associated with reduction in the height
of the airway surface liquid layer (see Figure 1). Our re-
sults also show that cigarette smoke has a more sup-
pressive effect on CFTR protein than messenger RNA
(see Figures 1 and 2) suggesting that strategies to re-
store CFTR in smokers should act at the protein level.
The composition of cigarette smoke varies markedly,
especially according to the geographic origin of the to-
bacco leaves and contains many pollutants such as metals
[22,31]. The composition of inhaled cigarette smoke by
smokers depends also on whether the cigarettes smoked
are filtered or not. Unfortunately, we do not know whether
the patients included in this study smoked filtered or non-
filtered cigarettes. Our data indicate that “acute” exposure
of airway epithelial cells to cigarette smoke extract prepared
from filtered cigarettes has minimal down-regulation effect
Figure 5 Metals present in CSE regulate CFTR expression.
16HBE14o- cells were incubated with 10% CSE before and after
incubation with Chelex-100 beads, in absence or presence of 10 μM
cadmium chloride. CFTR protein was detected by immunoblotting
48 hours after treatment. Blots are representative of at least three
independent experiments. *p < 0.05.
Figure 4 Metal analysis of lung samples from GOLD 0 and GOLD 4 COPD patients. The amount of aluminum (A), cadmium (B), chromium
(C), copper (D), manganese (E), and zinc (F) were measured in lung biopsies from GOLD 0 and GOLD 4 patients. Data are expressed in μg/mg
dry weight tissue. N = 8 for number of patients GOLD 0 (the never smoker patient was excluded) and N = 11 for number of patients COPD
GOLD 4.
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since smokers are exposed to cigarette smoke chronically
it is possible that the cumulative effect of chronic expos-
ure to filtered cigarettes decreases CFTR expression as
well. The down-regulation of CFTR expression by CSE
could be recapitulated after addition of the toxic metal
cadmium to Chelex-treated CSE, which demonstrated no
effect on CFTR alone. Cadmium concentration has been
found to be around 30 μM in the lungs of smokers and
7 μM in the aortas [32-34]. These results are in agreement
with our previous study showing that cadmium, aFigure 6 Manganese and cadmium decrease the expression of
CFTR in bronchial epithelial cells. 16HBE14o- cells were incubated
with cadmium chloride (CdCl2) or manganese chloride (MnCl2) at
the doses indicated for 24 hours. CFTR protein was detected by
immunobloting using a monoclonal antibody as described in
Materials and Methods.
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expression and function of the CFTR chloride channel [9].
Many metals have been shown to be present in cigarette
smoke, including aluminum, cadmium, chromium, cop-
per, lead, manganese, mercury, nickel, selenium, vanadium
and zinc [22]. Interestingly, only cadmium and manganese
were present in higher amounts in GOLD 4 COPD patient
lung samples when compared to samples from control
GOLD 0 patients. In addition, the content of other metals
present in cigarette smoke were similar in GOLD 0 and
GOLD 4 samples even though patients in the GOLD 0
group had higher “stop years” and lower “smoking pack-
year” than the GOLD 4 group (see Table 1). Manganese is
an essential element but high amounts can be toxic. Man-
ganese inhalation has been linked to chronic coughing,
acute bronchitis, and decreased lung function [35]. To our
knowledge, elevated accumulation of manganese in the
lung of smokers has not been previously reported. It was
surprising to detect such a difference in manganese, since
most of our patients were ex-smokers who had quit smok-
ing for over 7 years and the biologic half-life of manganese
has been reported to be around 40 days [36]. Future stud-
ies should evaluate the contribution of manganese to lung
diseases but our data shows that manganese decreases the
expression of CFTR in bronchial epithelial cells (see
Figure 6). On the other hand, cadmium is known to have
an extremely long biological half-life (10–30 years) [37].
Interestingly, cadmium inhalation has been reported to be
associated with the development of COPD in humans and
animals [38-40].
Conclusions
Our study shows that CFTR expression is decreased in
the lung of patients with severe COPD and is associated
with accumulation of the metals cadmium and manga-
nese in the lung. Due to the important role played by
CFTR in the lung, future studies should assess the effect
of pharmacological and/or natural compounds that increase/
protect CFTR in order to maintain normal lung func-
tion and prevent pathologic manifestations that could
lead to chronic bronchitis.
Additional file
Additional file 1: Figure S1. Effect of CSE prepared from filtered and
non-filtered cigarettes on CFTR expression. 16HBE14o- cells were
incubated with 10% CSE prepared from filtered or non-filtered cigarettes.
CFTR protein was detected by immunoblotting as described in Methods
section. Blots are representative of three independent experiments.
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